APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults

Journal of Nutrition

Volumn 140, Issue 4, 2010, Pages 773-778

  Gomez, Purificacion ^a   Perez Martinez, Pablo ^a   Marin, Carmen ^a   Camargo, Antonio ^a   Yubero Serrano, Elena Maria ^a   Garcia Rios, Antonio ^a   Rodriguez, Fernando ^b   Delgado Lista, Javier ^a   Perez Jimenez, Francisco ^a   Lopez Miranda, Jose ^a  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID;

ADULT; ALLELE; APOA1 GENE; APOA4 GENE; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FAT INTAKE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LIPID OXIDATION; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIET; DIETARY FATS; GENOTYPE; HUMANS; MIDDLE AGED; OXIDATION-REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77949713142     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.115964     Document Type: Article

References (43)

1. De Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. Arterioscler Thromb. 1993;13:712-9.
2. Dejager S, Bruckert E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res. 1993;34:295-308.
3. Austin MA, Talmud PJ, Luong LA, Haddad L, Day IN, Newman B, Edwards KL, Krauss RM, Humphries SE. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet. 1998;62:406-19.
4. Talmud PJ, Edwards KL, Turner CM, Newman B, Palmen JM, SE Humphries, Austin MA. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter. Circulation. 2000;101:2461-6.
5. Allayee H, Aouizerat BE, Cantor RM, Dallinga-Thie GM, Krauss RM, Lanning CD, Rotter JI, Lusis AJ, de Bruin TW. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am J Hum Genet. 1998;63:577-85.
6. Allayee H, Dominguez KM, Aouizerat BE, Krauss RM, Rotter JI, Lu J, Cantor RM, de Bruin TW, Luis AJ. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J Lipid Res. 2000;41:245-52.
7. Austin MA, Stephens K, Walden CE, Wijsman E. Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype. Atherosclerosis. 1999;142:79-87.
8. Rainwater DL, Almasy L, Blangero J, Cole SA, VandeBerg JL, MacCluer JW, Hixson JE. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol. 1999;19:777-83.
9. Dreon DM, Fernstrom HA, Willians PT, Krauss RM. Avery low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr. 1999;69:411-8.
10. Krauss RM, Dreon DM. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr. 1995;62:S478-87.
11. Kratz M, Gulbahce E, von Eckardstein A, Cullen P, Cignarella A, Assmann G, Wahrburg U. Dietary mono-and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr. 2002;132:715-8.
12. Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L, Luheranta A, Meyer BJ, Riccardi G. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis. 2003;167:149-58.
13. Moreno JA, Perez-Jimenez F, Marin C, Gomez P, Perez-Martinez P, Moreno R, Bellido C, Fuentes F, Lopez-Miranda J. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr. 2004;134:2517-22.
14. Delgado-Lista J, Perez-Jimenez F, Gavilan E, Marin C, Fuentes F, Fernandez-de la Puebla RA, Perez-Martinez P, Paniagua JA, Aguilera C, et al. A carbohydrate-rich diet reduces LDL size in QQ homozygotes for the Gln192Arg polymorphism of the paraoxonase 1 gene. Lipids. 2005;40:471-6.
15. Jeenah M, Kessling A, Miller N, Humphries SE. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 1990;7:233-41.
16. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C, Barelle FE. Human apolipoprotein A-I gene promoter polymorphism: association withhyperalphalipoproteinemia. J Lipid Res. 1990;31:1371-7.
17. Matsunaga A, Sasaki J, Mori T, Moriyama K, Nishi K, Hidaka K, Arakawa K. Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls. Nutr Metab Cardiovasc Dis. 1995;5:269-75.
18. Bossé Y, Pérusse L, Vohl MC. Genetic of LDL particle atherogenity: from genetic epidemiology to DNA-based variations. J Lipid Res. 2004;45:1008-26.
19. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, Lahoz C, Cucinota D, Couture P, et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham Offspring Study. Atherosclerosis. 2001;158:173-81.
20. Cendoroglo MS, Lahoz C, Martinez TRL, Ordovas JM, Lamon-Fava S, Cupples A, Wilson PW, Schaefer EJ. Association of A-IV 360 (Gln-His) polymorphism with plasma lipid and lipoproteins: the Framingham Offspring Study. Atherosclerosis. 2005;179:169-75.
21. Human Nutrition Information Service, USDA. Composition of foods. Agriculture handbook no.8. Washington, DC: US Government Printing Office; 1987.
22. Varela G. Tablas de composición de alimentos (Food composition tables). Madrid: Instituto de Nutrición CSIC; 1980.
23. Ruiz-Gutierrez V, Prada JL, Pérez-Jiménez F. Determination of fatty acid and triacylglycerol composition of human very-low-density lipoproteins. J Chromatogr. 1993;622:117-24.
24. Allain CC, Poon LS, Chang CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.
25. Bucolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 1973;19:476-82.
26. 2. Clin Chem. 1983;29:2026-30.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of a preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
28. Riepponem P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins AI-I and B serum. Scand J Clin Lab Invest. 1947;47:739-44.
29. Esterbauer H, Striegl G, Phul H, Rotheneder M. Continous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:67-75.
30. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
31. Austin MA, Krauss RM. Genetic control of low-density lipoprotein subclasses. Lancet. 1986;2:592-5.
32. Marin C, Lopez-Miranda J, Gomez P, Paz E, Perez-Martinez P, Fuentes F, Jimenez-Pereperez JA, Ordovas JM, Perez-Jimenez F. Effects of the human apolipoprotein AI promoter G-A mutation on postprandial lipoprotein metabolism. Am J Clin Nutr. 2002;76:319-25.
33. Lopez-Miranda J, Jansen S, Ordovas JM, Salas S, Marin C, Castro P, Ostos MA, Cruz G, Lopez-Segura F, et al. Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein- cholesterol response to dietary monounsaturated fat. Am J Clin Nutr. 1997;66:97-103.
34. Mata P, López-Miranda J, Pocovi M, Alonso R, Lahoz C, Marin C, Garces C, Cenarro A, Perez-Jimenez F, et al. Human apolipoprotein AI-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis. 1998;137:367-76.
35. Desroches S, Lamarche B. Diet and low-density-lipoprotein-size. Curr Atheroscler Rep. 2004;6:453-60.
36. Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin M. Dietary polyunsaturated fatty acid regulation of gene transcription. Prog Lipid Res. 1996;35:227-41.
37. Smith JD, Brinton EA, Breslow JL. Polymorphism in the human apolipoprotein AI gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest. 1992;89:1796-800.
38. Matsunaga A, Sasaki J, Han H, Matsunaga A, Sasaki J, Han H, Huang W, Kugi M, Koga T, et al. Compound heterozygosis for an apolipoprotein AI gene promoter mutation and a structural nonsense mutation with apolipoprotein AI deficiency. Arterioscler Thromb Vasc Biol. 1999;19:348-55.
39. Angotti E, Mele E, Costanzo F, Avvedimento EV. A polymorphism (G-A transition) in the -78 position of the apolipoprotein AI promoter increases transcription efficiency. J Biol Chem. 1994;269:17371-4.
40. Danek GM, Valenti M, Baralle FE, Romano M. The A/G polymorphism in the -78 position of the apolipoprotein AI promoter not has a direct effect on transcriptional efficiency. Biochim Biophys Acta. 1998;1398:67-74.
41. Ordovas JM, Corella D, Cupples A, Demissie S, Kelleher A, Coltell O, Wilson PWF, Schaefer EJ, Tucker K. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr. 2002;75:38-46.
42. Ostos MA, López-Miranda J, Ordovas JM, Marin C, Blanco A, Castro P, Lopez-Segura F, Jimenez-Pereperez J, Perez-Jimenez F. Dietary fat clearance is modulated by genetic variation in apolipoprotein A-IV gene locus. J Lipid Res. 1998;39:2493-500.
43. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA. 1991;88:8342-6.